Connect your AI

AptarGroup ATR Contract Liabilities

Contract Liabilities at other companies

West Pharmaceutical ServicesWST

——

Baxter InternationalBAX

——

Halozyme TherapeuticsHALO

——

IR

Ingersoll RandIR

——

DoverDOV

——

Other financials

Income statement

Revenue$982.9M+10.8%

Gross profit$351.9M+4.6%

Operating income$107.5M-5.2%

Net income$72.7M-7.8%

EPS (diluted)$1.12-4.3%

Balance sheet

Cash & equivalents$225.0M+78.8%

Total debt$1.4B+32.7%

Total equity$2.6B+3.6%

Total assets$5.1B+12.6%

Cash flow

Operating cash flow$118.7M+43.5%

CapEx$65.4M+15.0%

Free cash flow$53.3M+106%

Valuation

Market cap$7.68B-17.9%

Enterprise value$8.89B-13.9%

P/E19.9×-5.4×

P/S2×-0.6×

Profitability

Gross margin36.7%-1.6pp

Operating margin12.8%-1.2pp

Net margin10%-0.4pp

FCF margin8.4%-2.1pp

Returns & leverage

Return on equity15%-0.2pp

Debt / equity0.5×+0.1×

Current ratio1.7×+0.4×

Where this comes from

Reported directly by AptarGroup in its filing.

Tagged under the XBRL concept us-gaap:ContractWithCustomerLiabilityNoncurrent.

The official record: AptarGroup’s 10-Q, filed May 1, 2026, on SEC EDGAR. View the filing →

Ask your AI about AptarGroup's contract liabilities.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Harbor at dusk

Questions, answered.

What is AptarGroup's contract liabilities?: AptarGroup (ATR) reported contract liabilities of $47.84M in Q1 2026.
How has AptarGroup's contract liabilities changed year-over-year?: AptarGroup's contract liabilities increased by 3.1% year-over-year, from $46.4M to $47.84M.
What is the long-term trend for AptarGroup's contract liabilities?: Over 5 years (2020 to 2025), AptarGroup's contract liabilities has grown at a 18.2% compound annual growth rate (CAGR), from $21.58M to $49.9M.
What does contract liabilities mean?: Revenue collected or billed in advance of performance — deferred revenue under ASC 606 terminology, representing future revenue obligations.